메뉴 건너뛰기




Volumn 89, Issue 1, 2003, Pages 57-69

Investigations on the drug releasing mechanism from an asymmetric membrane-coated capsule with an in situ formed delivery orifice

Author keywords

Asymmetric membrane; Cellulose acetate; In situ formation; Nifedipine; Osmotic pressure

Indexed keywords

CHLOROPHYLL; OSMOSIS; SOLUBILITY; STAINLESS STEEL;

EID: 0037437074     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(03)00091-9     Document Type: Article
Times cited : (48)

References (22)
  • 1
    • 0016830071 scopus 로고
    • Elementary osmotic pump
    • Theeuwes F. Elementary osmotic pump. J. Pharm. Sci. 64:1975;1987-1991.
    • (1975) J. Pharm. Sci. , vol.64 , pp. 1987-1991
    • Theeuwes, F.1
  • 3
    • 0026088482 scopus 로고
    • Osmotic pumping release from KCl tablets coated with porous and non-porous ethylcellulose
    • Lindstedt B., Sjöbert M., Hjärtatam J. Osmotic pumping release from KCl tablets coated with porous and non-porous ethylcellulose. Int. J. Pharm. 67:1991;21-27.
    • (1991) Int. J. Pharm. , vol.67 , pp. 21-27
    • Lindstedt, B.1    Sjöbert, M.2    Hjärtatam, J.3
  • 4
    • 0029076668 scopus 로고
    • Osmotic drug delivery: A review of the patent literature
    • Santus G., Baker R.W. Osmotic drug delivery: a review of the patent literature. J. Controlled Release. 35:1995;1-21.
    • (1995) J. Controlled Release , vol.35 , pp. 1-21
    • Santus, G.1    Baker, R.W.2
  • 5
    • 0037133084 scopus 로고    scopus 로고
    • Formulation aspects in the development of osmotically controlled oral drug delivery systems
    • Verma R.K., Krishna D.M., Garg S. Formulation aspects in the development of osmotically controlled oral drug delivery systems. J. Controlled Release. 79:2002;7-27.
    • (2002) J. Controlled Release , vol.79 , pp. 7-27
    • Verma, R.K.1    Krishna, D.M.2    Garg, S.3
  • 7
    • 0032932451 scopus 로고    scopus 로고
    • Asymmetric membrane capsules for osmotic drug delivery. I. Development of a manufacturing process
    • Thombre A.G., Cardinal J.R., DeNoto A.R., Herbig S.M., Smith K.L. Asymmetric membrane capsules for osmotic drug delivery. I. Development of a manufacturing process. J. Controlled Release. 57:1999;55-64.
    • (1999) J. Controlled Release , vol.57 , pp. 55-64
    • Thombre, A.G.1    Cardinal, J.R.2    DeNoto, A.R.3    Herbig, S.M.4    Smith, K.L.5
  • 8
    • 0032899395 scopus 로고    scopus 로고
    • Asymmetric membrane capsules for osmotic drug delivery. II. In vitro and in vivo drug release performance
    • Thombre A.G., Cardinal J.R., DeNoto A.R., Gibbes D.C. Asymmetric membrane capsules for osmotic drug delivery. II. In vitro and in vivo drug release performance. J. Controlled Release. 57:1999;65-73.
    • (1999) J. Controlled Release , vol.57 , pp. 65-73
    • Thombre, A.G.1    Cardinal, J.R.2    DeNoto, A.R.3    Gibbes, D.C.4
  • 9
    • 85031200891 scopus 로고    scopus 로고
    • Oral osmotic system for slightly soluble active agents, U.S. Patent 5,284,662, Feb. 8, 1994
    • A.D. Koparkar, S.B. Shah, Oral osmotic system for slightly soluble active agents, U.S. Patent 5,284,662, Feb. 8, 1994.
    • Koparkar, A.D.1    Shah, S.B.2
  • 10
    • 85031206864 scopus 로고    scopus 로고
    • Dispensing devices powered by lyotropic liquid crystals, U.S. Patent 5,108,756, April 28, 1992
    • W.J. Curatolo, Dispensing devices powered by lyotropic liquid crystals, U.S. Patent 5,108,756, April 28, 1992.
    • Curatolo, W.J.1
  • 11
    • 85031209240 scopus 로고    scopus 로고
    • Dispensing devices powered by lyotropic liquid crystals, U.S. Patent 5,030,452, Jan. 12, 1989
    • W.J. Curatolo, Dispensing devices powered by lyotropic liquid crystals, U.S. Patent 5,030,452, Jan. 12, 1989.
    • Curatolo, W.J.1
  • 12
    • 85031210411 scopus 로고    scopus 로고
    • Delivery device having encapsulated excipients, U.S. Patent 5,697,922, Dec. 6, 1997
    • A.G. Thombre, Delivery device having encapsulated excipients, U.S. Patent 5,697,922, Dec. 6, 1997.
    • Thombre, A.G.1
  • 13
    • 0032765727 scopus 로고    scopus 로고
    • Delivery of glipizide from asymmetric membrane capsules using encapsulated excipients
    • Thombre A.G., DeNoto A.R., Gibbes D.C. Delivery of glipizide from asymmetric membrane capsules using encapsulated excipients. J. Controlled Release. 60:1999;333-341.
    • (1999) J. Controlled Release , vol.60 , pp. 333-341
    • Thombre, A.G.1    DeNoto, A.R.2    Gibbes, D.C.3
  • 15
    • 85031195005 scopus 로고    scopus 로고
    • Oral osmotic system for slightly soluble active agents, U.S. Patent 5,284,662, Feb. 8, 1994
    • A.D. Koparkar, S.B. Shah, Oral osmotic system for slightly soluble active agents, U.S. Patent 5,284,662, Feb. 8, 1994.
    • Koparkar, A.D.1    Shah, S.B.2
  • 16
    • 85031202552 scopus 로고    scopus 로고
    • Process for forming outlet passageways in pills using a laser, U.S. Patent 4,088,864, May 9, 1978
    • F. Theeuwes, R.J. Saunders, W.S. Mefford, Process for forming outlet passageways in pills using a laser, U.S. Patent 4,088,864, May 9, 1978.
    • Theeuwes, F.1    Saunders, R.J.2    Mefford, W.S.3
  • 17
    • 85031201185 scopus 로고    scopus 로고
    • Method and apparatus for forming a hole in a drug dispensing device, U.S. Patent 5,071,607, Dec. 10, 1991
    • A.D. Ayer, H.H. Balkie, Method and apparatus for forming a hole in a drug dispensing device, U.S. Patent 5,071,607, Dec. 10, 1991.
    • Ayer, A.D.1    Balkie, H.H.2
  • 19
    • 0022408524 scopus 로고
    • Osmotic flow through controlled porosity films: An approach to delivery of water-soluble compounds
    • Zentner G.M., Rork G.S., Himmelstein K.J. Osmotic flow through controlled porosity films: an approach to delivery of water-soluble compounds. J. Controlled Release. 2:1985;217-229.
    • (1985) J. Controlled Release , vol.2 , pp. 217-229
    • Zentner, G.M.1    Rork, G.S.2    Himmelstein, K.J.3
  • 20
    • 85031205157 scopus 로고    scopus 로고
    • Controlled porosity osmotic pump, U.S. Patent 4,968,507, Nov. 6, 1990
    • G.M. Zentner, G.S. Rork, K.J. Himmelstein, Controlled porosity osmotic pump, U.S. Patent 4,968,507, Nov. 6, 1990.
    • Zentner, G.M.1    Rork, G.S.2    Himmelstein, K.J.3
  • 21
    • 85031200069 scopus 로고    scopus 로고
    • Controlled release formulation for water-insoluble drugs in which a passageway is formed in situ, U.S. Patent 5,736,159, April 7, 1998
    • C. Chen, D. Lee, J. Xie, Controlled release formulation for water-insoluble drugs in which a passageway is formed in situ, U.S. Patent 5,736,159, April 7, 1998.
    • Chen, C.1    Lee, D.2    Xie, J.3
  • 22
    • 0023253740 scopus 로고
    • Release characteristics of nifedipine sustained release granules in vitro and healthy subjects
    • Kohri N., Miyazaki K., Arita T., Shimono H., Nomura A., Yasuda H. Release characteristics of nifedipine sustained release granules in vitro and healthy subjects. Chem. Pharm. Bull. 35:1987;2504-2509.
    • (1987) Chem. Pharm. Bull. , vol.35 , pp. 2504-2509
    • Kohri, N.1    Miyazaki, K.2    Arita, T.3    Shimono, H.4    Nomura, A.5    Yasuda, H.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.